Consensus Estimate
10x Genomics Faces Profitability Challenges: Analyst Highlights Uncertainties in 2025 NIH Funding Guidance
10x Genomics Faces Profitability Challenges 10x Genomics Inc (NASDAQ:TXG) recently announced a loss for the fourth quarter, reporting earnings per ... Read more
Discover Why DXC Technology (DXC) is Emerging as a Must-Buy Stock Right Now!
DXC Technology Company (DXC) has recently been upgraded to a Zacks Rank #1, also known as a Strong Buy. This ... Read more
